Barbara Ryan | Investor Relations |
Greg Williams | Chief Executive Officer |
Tom Haverty | Chief Medical Officer |
Matthew Goddeeris | Vice President of Research |
Stephen MacDonald | Vice President of Finance and Accounting |
Joel Beatty | Citi |
Lina Kaminski | Canaccord |
Ted Tenthoff | Piper Sandler |
Yun Zhong | Janney |
Good afternoon, everyone and welcome to Eloxx Pharmaceuticals Fourth Quarter and Full Year 2019 Earnings Webcast and Conference call. Today’s call is being recorded.
At this time, I would like to turn the call over to Barbara Ryan, Eloxx's Investor Relations. Please begin.
Thank you, Gigi.